Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Lions

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
AIDS Research and Therapy|March 16, 2022
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)Tangui Barré, Patrick Mercié, Caroline Lions, et al.
Antiviral Therapy|October 30, 2013
Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohortPerrine Roux, Caroline Lions, Julien Cohen, et al.
Cancers|January 21, 2022
Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Cyrille Delpierre, et al.
Drug and Alcohol Review|April 14, 2016
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)Fabienne Marcellin, Caroline Lions, Eric Rosenthal, et al.
AIDS (London, England)|November 26, 2019
Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015Isabelle Poizot-Martin, Caroline Lions, Antoine Cheret, et al.
HIV Medicine|August 9, 2022
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP studyCaroline Lions, Helene Laroche, Marion Mora, et al.
Addiction (Abingdon, England)|February 21, 2013
Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort)Fabienne Marcellin, Caroline Lions, Maria Winnock, et al.
Addiction (Abingdon, England)|August 4, 2015
Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention studyPerrine Roux, Jean-Marie Le Gall, Marie Debrus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2015
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)Maria Patrizia Carrieri, Lawrence Serfaty, Antoine Vilotitch, et al.
Medicine|June 8, 2018
Risk factors associated with overweight and obesity in HIV-infected people: Aging, behavioral factors but not cART in a cross-sectional studyVéronique Obry-Roguet, Sylvie Brégigeon, Carla E Cano, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
AIDS Research and Therapy|March 16, 2022
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)Tangui Barré, Patrick Mercié, Caroline Lions, et al.
Antiviral Therapy|October 30, 2013
Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohortPerrine Roux, Caroline Lions, Julien Cohen, et al.
Cancers|January 21, 2022
Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Cyrille Delpierre, et al.
Drug and Alcohol Review|April 14, 2016
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)Fabienne Marcellin, Caroline Lions, Eric Rosenthal, et al.
AIDS (London, England)|November 26, 2019
Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015Isabelle Poizot-Martin, Caroline Lions, Antoine Cheret, et al.
HIV Medicine|August 9, 2022
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP studyCaroline Lions, Helene Laroche, Marion Mora, et al.
Addiction (Abingdon, England)|February 21, 2013
Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort)Fabienne Marcellin, Caroline Lions, Maria Winnock, et al.
Addiction (Abingdon, England)|August 4, 2015
Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention studyPerrine Roux, Jean-Marie Le Gall, Marie Debrus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2015
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)Maria Patrizia Carrieri, Lawrence Serfaty, Antoine Vilotitch, et al.
Medicine|June 8, 2018
Risk factors associated with overweight and obesity in HIV-infected people: Aging, behavioral factors but not cART in a cross-sectional studyVéronique Obry-Roguet, Sylvie Brégigeon, Carla E Cano, et al.
Pageof 4